Cabaletta Bio Inc. (NASDAQ:CABA) is one of the top penny stocks to buy in investors’ stock portfolio. On May 14, Cabaletta Bio Inc. (NASDAQ:CABA) delivered positive clinical and translational data from the first four patients in the lowest dose cohort evaluating preconditioning-free (PC-free) rese-cel, an investigational, autologous CAR T cell therapy for the treatment of autoimmune diseases.
It also presented manufacturing and translational data from the first two autoimmune patients treated with rese-cel treated using Cellares Cell Shuttle platform. It became clear that a higher rese-cel dose would be required in the absence of preconditioning. In addition, 50% of the patients demonstrated compelling, drug-free responses for six months.
Consequently, PC-free rese-cel has the potential to enhance access for patients in CAR T centers. The company has already signed a long-term commercial supply agreement that will ensure rese-cel is produced for thousands of patients at the lowest cost of goods, with minimal capital investment.
Cabaletta is on track to announce initial data from the lowest-dose cohort of lupus patients dosed with preconditioning. The company also plans to advance rese-cel toward BLA submission as it eyes a commercial launch.
Cabaletta Bio is a clinical-stage biotechnology company developing engineered T-cell therapies designed to reset the immune system and provide potentially curative treatments for patients with autoimmune diseases.
While we acknowledge the potential of CABA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: Top 10 Small Cap Stocks With Huge Growth Potential and Renaissance Technologies Returns, AUM, CEO and Top 10 Semiconductor Stock Picks.
Disclosure: None. Follow Insider Monkey on Google News.
Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: finance.yahoo.com
